Pfizer Inc – CRI Report

Dietary Supplements in the Age of Personalized Nutrition Market Research Report – Global Forecast Till 2023

admin — Fri, 04 Jan 2019 05:53:05 +0000

Market Analysis
With the increasing problems of malnutrition and poor health, it has become very much important for people to get hold of the best dietary supplements. These supplements are consumed to increase the level of consumption. These supplements have biological benefits if consumed regularly. The supplements generally include those substances that are beneficial to health, like fiber, amino acids, minerals, vitamins, fatty acids, and other substances. The global dietary supplements in the age of personalized nutrition market are expected to grow at a CAGR of 6.90% during the forecast period 2017-2023.
One of the main driving forces that are affecting the growth of this market is an individual lifestyle and changing food habits of the people. Fluctuation in the nutrition content of the food is also another factor that is affecting the market. In the age of personalized nutrition, the dietary supplements are considered to be the major reasons for drastic changes in the healthcare sector due to its ability to offer one with improvised drug delivery system along with better patient care or individual treatment process. Advancements made in the preparation of the dietary supplements along with the superior drug formulation processes is expected to uplift the global dietary supplements in the age of personalized nutrition market.
Market Segmentation
The global dietary supplements in the age of personalized nutrition market are categorized on the basis of its product category, gender, application, end user, dosage form and regional demand. Based on its product category, the market is segmented into herbs & botanicals, vitamins, sports supplements, minerals, meal supplements, and others. Based on its gender, the global dietary supplements in the age of personalized nutrition market is segmented into male and female. On the basis of its application, the global market is classified into lifestyle diseases, genetic predispositions, inherited diseases, and others. On the basis of its dosage form, the market is sectioned into tablets, powder, soft gels, capsules, liquids, and others. Based on its end users, the market is divided into home care, hospitals & clinics, and others.
Regional Analysis
Geographically, the global dietary supplements in the age of personalized nutrition market are divided into global regions like Europe, North America, Asia- Pacific, Middle East, LATAM, and Africa.
Major Players
Some of the major players in the global dietary supplements in the age of personalized nutrition market include companies like Nestlé Health Science, Carlyle Group, Danone Nutricia, Amway (Nutrilite), Abbott Laboratories, Archer Daniels Midland, Herbalife International, Danisco, Amway, Glanbia, GlaxoSmithKline plc, Pfizer Inc., Bayer AG, Balchem Corporation, Bactolac Pharmaceutical Inc., Natures Product Inc., among others.

The post Dietary Supplements in the Age of Personalized Nutrition Market Research Report – Global Forecast Till 2023 first appeared on CRI Report.

Global Sturge-Weber Syndrome Market Research Report – Forecast To 2023

admin — Mon, 24 Dec 2018 02:00:59 +0000

Introduction
Sturge-Weber syndrome (SWS) is a neurological disorder that is present at birth. The affected individual has a noticeable distinctive port-wine stain on the forehead, scalp, or around the eye. This stain is a birthmark caused by a blood vessel abnormality. A large number of people with SWS also suffers from seizures or convulsions. Sturge-Weber syndrome develops a blood vessel abnormality called leptomeningeal angiomas in the brain. Other features of this SWS syndrome include glaucoma, paralysis, developmental delay, and intellectual disability. The person suffering from this may also have other complications such as increased pressure in the eye, developmental delays, and weakness on one side of the body. However, the factors responsible for market growth include technological advancements, increasing awareness among people, and increasing government assistance.
However, increasing challenges in research and development, the high cost of treatment, and poor healthcare system may hamper the market growth.
The global sturge-weber syndrome market has been segmented by type, diagnosis and treatment, and end user.
The global sturge-weber syndrome market has been divided, by type into type 1, type 2 and type 3.
Based on diagnosis and treatment, the global sturge-weber syndrome market has been categorized into diagnosis and treatment.
On the basis of end user, the market has been classified as hospitals and clinics and diagnostic centers.
The global sturge-weber syndrome market was valued at USD 2277.4 million in 2017 and is expected to register a CAGR of 5.3 % during the forecast period from 2018 to 2023.

Key Players
Some of the key players in the global sturge-weber syndrome market are Abbott, Pfizer Inc, F. Hoffmann-La Roche AG, Novartis AG, UCB SA, Sanofi, Shire, Aleva Neurotherapeutics SA, GW Pharmaceuticals, PLC, ElectroCore LLC, and Johnson & Johnson.
Objectives of the Study
? To provide a detailed analysis of the market structure along with a forecast of various segments and sub-segments of the global sturge-weber syndrome market
? To provide insights into factors influencing and affecting market growth
? To provide historical and forecast revenue of market segments and sub-segments with respect to countries
? To provide strategic profiling of key players in the market and comprehensively analyzing their market share, core competencies, and drawing a competitive landscape for the market
? To provide economic factors that influence the global sturge-weber syndrome market
? To provide a detailed analysis of the value chain and supply chain of the global sturge-weber syndrome market
Target Audience
? Potential Investors
? Associations
? Government Research Institutes
? End Users
? Raw Material Suppliers
? Drugs Suppliers and Manufacturers
Key Findings
? The global sturge-weber syndrome market is expected to reach USD 2277.4 million by 2023 at a CAGR of 5.3 % from 2018 to 2023.
? On the basis of type, the type 1 segment accounted for the largest market share of 47.44% in 2017 and is expected to be USD 792.6 million by 2023.
? The market in the Americas is expected to account for the largest share of the global sturge-weber syndrome market and is projected to reach USD 812.2 million by 2023.
? The market in Asia-Pacific is projected to be the fastest growing at a CAGR of 5.9 % from 2018 to 2023.

Regional Analysis
? Americas
o North America
? US
? Canada
o Latin America
? Europe
o Germany
o France
o UK
o Italy
o Spain
o Rest of Europe
? Asia-Pacific
o Japan
o China
o India
o Australia
o South Korea
o Rest of Asia-Pacific
? Middle East & Africa
o Middle East
o Africa

The post Global Sturge-Weber Syndrome Market Research Report – Forecast To 2023 first appeared on CRI Report.

Global Active Pharmaceutical Ingredients Market Research Report – Forecast to 2023

admin — Fri, 07 Dec 2018 02:40:51 +0000

Introduction
Active pharmaceutical ingredient (API) is a biologically active pharmaceutical drug. API can be obtained by a synthetic process or from natural sources. The increasing occurrence of chronic diseases, rising acceptance, and uptake of pharmaceuticals, growth in abbreviated new drug applications (ANDA), and the growing importance of generics are expected to drive market growth. For instance, according to the report published by the Centers for Disease Control and Prevention (CDC), nearly 92.1 million adults in the US dealt with at least one type of cardiovascular diseases in 2017. However, stringent regulatory policies and adverse drug price control policies across numerous countries may hamper the growth of the market.
The global active pharmaceutical ingredient market is expected to reach to a market value of USD 215,125.4 million by 2023 from USD 161,143.2 million in 2017 and is expected to register a CAGR of 4.93% during the forecast period from 2018 to 2023. In 2016, the market was led by the Americas with a 40.7% share, followed by Europe and Asia-Pacific with shares of 27.0% and 24.8%, respectively. The increasing burden of chronic diseases has been observed in different parts of the world which has upsurge the growth of the market.
The global active pharmaceutical ingredients market is segmented by manufacturing process, by type of synthesis, by API formulation, by application, by molecule, and by region.
The global active pharmaceutical ingredients market, by manufacturing process, is segmented into captive manufacturing and contract manufacturing.
The global active pharmaceutical ingredients market, by type of synthesis, is segmented into synthetic and biotech.
The global active pharmaceutical ingredients market, by API formulation, is segmented into generic API and innovative API.
By application, the global active pharmaceutical ingredients market is segmented into cardiovascular disease, oncology, neurological disorders, orthopedic disorders, respiratory, gastrointestinal disorders, urology, and others.
By molecule, the global active pharmaceutical ingredients market is segmented into small molecule and large molecule.
The global active pharmaceutical ingredient market is expected to reach to a market value of USD 215,125.4 million by 2023 from USD 161,143.2 million in 2017 and is expected to register a CAGR of 4.93% during the forecast period from 2018 to 2023.
Key Players
Sanofi, Bayer AG, Pfizer Inc., F. Hoffmann-La Roche AG, Abbott Laboratories, Merck & Co., Inc, Boehringer Ingelheim GmbH, GlaxoSmithKline Plc (GSK), Novartis AG, Eli Lilly and Company, and Teva Pharmaceutical Industries Ltd, and others.
Study objectives
• To provide a detailed analysis of the market structure along with the forecast of various segments and sub-segments of the active pharmaceutical ingredients market
• To provide insights into factors affecting the market growth
• To analyze the global active pharmaceutical ingredients market based on various tools such as supply chain analysis and Porter’s five force analysis
• To provide historical and forecast revenue of market segments and sub-segments with respect to regions and their respective key countries
• To provide country-level analysis of the market with respect to current market size and future perspective
• To provide country-level analysis of the market for segments by manufacturing process, by type of synthesis, by API formulation, by application, by molecule, and by region
• To provide strategic profiling of key players in the market, comprehensively analyzing their core competencies, and drawing a competitive landscape for the market
• To track and analyze competitive developments such as joint ventures, strategic alliances, mergers and acquisitions, new product developments, and research and developments in the active pharmaceutical ingredients market
Target Audience
• Pharmaceutical and Biotechnology Companies
• Research and Development (R&D) Companies
• Government Research Institutes
• Academic Institutes and Universities
Key Findings
• The global active pharmaceutical ingredients market is expected to reach USD 215,125.4 million by 2023 from USD 161,143.2 million in 2017 and is expected to register a CAGR of 4.93% during the forecast period from 2018 to 2023.
• On the basis of manufacturing process, the captive manufacturing segment is expected to account for the largest market share at a CAGR of 4.78% by 2023
• Based on type of synthesis, the synthetic segment is expected to account for the largest market share at a CAGR of 4.89% by 2023
• Based on API formulation, the generic API segment is expected to account for the largest market share at a CAGR of 4.62% by 2023
• Based on application, the cardiovascular disease segment is expected to account for the largest market share at a CAGR of 3.74% by 2023
• Based on molecule, the small molecule segment is expected to account for the largest market share at a CAGR of 4.89% by 2023
• The Americas is expected to hold the largest share of the global active pharmaceutical ingredients market at a CAGR of 4.74% by 2023
• Asia-Pacific is the fastest growing market, which is expected to register a CAGR of 5.27% by 2023
Regional Analysis
• Americas
o North America
 US
 Canada
o South America
• Europe
o Germany
o France
o UK
o Italy
o Spain
o Rest of Europe
• Asia-Pacific
o Japan
o China
o India
o Australia
o Republic of Korea
o Rest of Asia-Pacific
• Middle East & Africa
o Middle East
o Africa

The post Global Active Pharmaceutical Ingredients Market Research Report – Forecast to 2023 first appeared on CRI Report.